Abstract
Parkinson's disease is a prevalent neurological disease characterized by profound and incapacitating movement disorders. A common pathology in Parkinson's patients is degeneration of substantia nigra dopaminergic neurons that innervate the striatum and a corresponding decrease in striatal dopamine content. We now report that NT-4/5 can prevent the death of rat embryonic substantia nigra dopaminergic neurons in low density, enriched, primary cultures. Furthermore, these neurons express messenger RNA encoding the trkB receptor for NT-4/5 and transcripts for NT-4/5 are present in their environment. In addition, we demonstrate that NT-4/5 protects embryonic dopaminergic neurons from the toxic effects of the neurotoxin MPP+. Thus, NT-4/5 could be a physiological survival factor for midbrain dopaminergic neurons and may be useful as a therapeutic agent for Parkinson's disease.
MeSH terms
-
1-Methyl-4-phenylpyridinium / toxicity
-
Animals
-
Cell Survival
-
Cells, Cultured
-
Corpus Striatum / chemistry
-
Corpus Striatum / cytology
-
Corpus Striatum / embryology
-
Dopamine / metabolism*
-
Nerve Growth Factors / pharmacology
-
Nerve Growth Factors / physiology*
-
Nerve Tissue Proteins / biosynthesis
-
Nerve Tissue Proteins / genetics
-
Nerve Tissue Proteins / pharmacology
-
Neurons / cytology*
-
Neurons / drug effects
-
Parkinson Disease / metabolism
-
Polymerase Chain Reaction
-
Rats
-
Receptor, Ciliary Neurotrophic Factor
-
Receptors, Growth Factor / biosynthesis
-
Receptors, Growth Factor / genetics
-
Substantia Nigra / cytology*
-
Substantia Nigra / embryology
-
Substantia Nigra / metabolism
-
Tyrosine 3-Monooxygenase / biosynthesis
-
Tyrosine 3-Monooxygenase / genetics
Substances
-
Nerve Growth Factors
-
Nerve Tissue Proteins
-
Receptor, Ciliary Neurotrophic Factor
-
Receptors, Growth Factor
-
neurotrophin 5
-
Tyrosine 3-Monooxygenase
-
neurotrophin 4
-
1-Methyl-4-phenylpyridinium
-
Dopamine